Friday, June 2, 2017

A startup that charges $8,000 for young blood transfusions swears they’re worth every penny

And so it starts. This company is touting disease-fighting, but as I understand it the benefit that has been proven (at least in mice) is reduced senescence:

https://qz.com/996190/ambrosia-says-a-transfusion-of-young-blood-plasma-lowered-disease-markers-in-a-human-trial/

No comments:

CATL's sodium hybrid battery will be 30% cheaper & revolutionise the world

Very cool…but it’s Chinese. Grr. https://youtu.be/h74Xj-WWwBc?si=mgYbSTTLUxVixZQV